Aclaris Therapeutics ACRS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $454.08M.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's market capitalization?
- Aclaris Therapeutics (ACRS) reported market capitalization of $454.08M in Q1 2026.
- How has Aclaris Therapeutics's market capitalization changed year-over-year?
- Aclaris Therapeutics's market capitalization increased by 174.4% year-over-year, from $165.47M to $454.08M.
- What is the long-term trend for Aclaris Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's market capitalization has grown at a -3.8% compound annual growth rate (CAGR), from $396.14M to $326.12M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.